首页> 外文OA文献 >Clinical significance of microvessel density in multiple myeloma patients.
【2h】

Clinical significance of microvessel density in multiple myeloma patients.

机译:多发性骨髓瘤患者微血管密度的临床意义。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To investigate the role of angiogenesis in multiple myeloma (MM), bone marrow biopsy from 75 adults with newly diagnosed, untreated MM were evaluated. Microvessels were scored in at least 3 areas ( x 200 fields) of the highest microvessel density in representative sections of each bone marrow specimen using immunohistochemistry for CD34. Prognostic variables were also evaluated for the overall survival. Microvessel counts were significantly higher in patients with MM (n=69.42+/-9.67), compared with control (n=26.81+/-2.85). Microvessel density had a weak correlation with percentage of bone marrow plasma cells. By univariate analysis, age, beta2-microglobulin, serum albumin, serum creatinine, serum calcium, hemoglobin, platelet count, and bone marrow plasma cell percentage were correlated with survival. By multivariate analysis, age, serum albumin, serum creatinine, hemoglobin, platelet count and bone marrow plasma cell percentage were correlated with overall survival, whereas microvessel density was not. In summary, microvessel density in bone marrow of MM is significantly increased compared to control, but was not correlated with overall survival. Further studies regarding angiogeneic molecules are needed to determine the functional role of angiogenesis in MM.
机译:为了研究血管生成在多发性骨髓瘤(MM)中的作用,对75例新诊断,未经治疗的MM成年人的骨髓活检进行了评估。使用CD34免疫组织化学方法,在每个骨髓标本的代表性切片中,在最高微血管密度的至少3个区域(x 200视野)中对微血管评分。还评估了总生存期的预后变量。与对照组(n = 26.81 +/- 2.85)相比,MM患者的微血管计数显着更高(n = 69.42 +/- 9.67)。微血管密度与骨髓浆细胞百分比具有弱相关性。通过单因素分析,年龄,β2-微球蛋白,血清白蛋白,血清肌酐,血清钙,血红蛋白,血小板计数和骨髓浆细胞百分比与生存率相关。通过多变量分析,年龄,血清白蛋白,血清肌酐,血红蛋白,血小板计数和骨髓浆细胞百分比与总生存率相关,而微血管密度与总生存率无关。总之,与对照相比,MM骨髓中的微血管密度显着增加,但与总生存率无关。需要进一步研究血管生成分子,以确定MM中血管生成的功能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号